1Inskip PD, Mellemkjaer L, Gridley G, et al. Incidence of intracranial tumors following hospitalization for head injuries (Denmark). Cancer Causes Control,1998,9:9.
2Fernandez PM, Brem S. Malignant brain tumors in the elderly. Clin Ceriatr Med,1997,13:327-338.
4Riva P, Franceschi G, Riva M, et al. Role of nuclear medicine in the treatment of malignant gliomas: the locoregional radioimmunotherpy approach. Eur J Nucl Med,2000,27: 601-609.
5Menei P, Benoit JP. Implantable drug-releasing biodegradable microspheres for local treatment of brain glioma. Acta Neurochir, 2003 Suppl,88:51-55.
6Jaaskelainen J. Non-invasive transcranial high-intensity focused ultrasound under MRI thermometry and guidance in the treatment of brain lesions. Acta Neurochir, 2003 Suppl,88:57-60.
7Bobo RH, Laske DW, Akbasak A, et al. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA,1994, 91: 2076-2080,
8Nguyen TT, Pannu YS, Sung C, et al. Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging. J Neurosurg,2003,98: 584-590.
9Occhiogrosso G, Edgar MA. Prolonged convection-enhanced delivery into the rat brainstem. Neurosurgery, 2003, 52: 388-393.
10Weber FW, Floeth F, Asher A, et al. Local convection enhanced delivery of IL4-pseudomonas exotoxin (NBI-3001 ) for treatment of patients with recurrent malignant glioma. Acta Neurochir, 2003 Suppl, 88:93-103.
